Tag: Prescription Drugs
Fewer Bleeding Events Seen With Abelacimab Than Rivaroxaban in A-Fib
Lower levels of free factor XI and fewer bleeding events seen in patients with atrial fibrillation at moderate-to-high risk for stroke
FDA Warns Sanofi of Manufacturing Irregularities at Key Facility
Agency cites contamination at Massachusetts plant where company makes ingredients used to produce various medicines
ART Pregnancies Have Higher Exposure to Teratogenic Medications
However, overall prevalence of exposure to teratogenic medicines is low
Trump Ends Push to Slash Prescription Drug Costs
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
Drug is the first and only approved monotherapy for refractory major depressive disorder
Certain Drug Types Associated With Risk for Dementia
Antimicrobials, vaccines, anti-inflammatories linked to reduced risk for Alzheimer disease and dementia; antipsychotics and diabetes drugs tied to higher risk
Zoledronate Prevents Morphometric Vertebral Fractures Over 10 Years
Zoledronate administered at baseline and five years effective for preventing fragility fracture, any fracture, major osteoporotic fracture
Glucarpidase Improves Outcomes in Patients With Methotrexate-Induced Kidney Toxicity
Glucarpidase associated with 2.70-fold increased odds of kidney recovery in methotrexate-acute kidney injury
Adjuvant Trastuzumab Emtansine Improves Overall Survival in HER2+ Breast Cancer
T-DM1 sustained the improvement in invasive disease-free survival over trastuzumab in HER2-positive early breast cancer
Differences Exist in Precision Oncology Drug Eligibility Among Patient Ancestral Groups
Patients of African ancestry had the lowest precision oncology drug-based clinical actionability from 2019 onward
